ABBVIE INC. vs. Forte Biosciences, Inc. Common Stock
ABBVIE INC. and Forte Biosciences, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABBV | FBRX | |
|---|---|---|
| Market Cap | $435.06 billion | $1.57 billion |
| Revenue (TTM) | $64.39 billion | — |
| Net Income (TTM) | $6.32 billion | — |
ABBV leads on 1 of 1 size & scale factors.
Valuation
| ABBV | FBRX | |
|---|---|---|
| P/E Ratio | 69.55 | — |
| Price / Book | -73.89 | — |
| Price / Sales | 6.76 | — |
ABBV and FBRX split the valuation factors evenly.
Profitability
| ABBV | FBRX | |
|---|---|---|
| Net Margin | 9.81% | — |
| Return on Equity | -107.29% | — |
ABBV and FBRX split the profitability factors evenly.
Dividend
| ABBV | FBRX | |
|---|---|---|
| Dividend Yield | 2.81% | — |
| Payout Ratio | 195.48 | — |
ABBV and FBRX split the dividend factors evenly.
Risk & Sentiment
| ABBV | FBRX | |
|---|---|---|
| Short Interest | 0.85% | 0.37% |
FBRX leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, FBRX overview, FBRX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.